He new formulation IDegAsp has been compared with two other distinct
He new formulation IDegAsp has been compared with two other diverse insulin analogs IGlar or biphasic IAsp.74,75 The very first 16week, openlabel, treattotarget trial has compared IDegAsp with IGlar in…